Have a personal or library account? Click to login
miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90+ HepG2 cells Cover

miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90+ HepG2 cells

Radiology and Oncology
Volume 46 (2012): Issue 3 (September 2012)
By: Lin Fang,  Hai-Bing Zhang,  Hua Li,  Yong Fu and  Guang-Shun Yang  
Open Access
|Apr 2012

References

  1. Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, et al. Liver stem cells and hepatocellular carcinoma. Hepatology 2009; 49: 318-29.10.1002/hep.22704272672019111019
    Search in Google Scholar
  2. Marquardt JU, Factor VM, Thorgeirsson SS. Epigenetic regulation of cancer stem cells in liver cancer: Current concepts and clinical implications. J Hepatol 2010; 53: 568-77.10.1016/j.jhep.2010.05.003349287720646772
    Search in Google Scholar
  3. Lingala S, Cui YY, Chen X, Ruebner BH, Qian XF, Zern MA, et al. Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp Mol Path 2010; 89: 27-35.10.1016/j.yexmp.2010.05.005290043420511115
    Search in Google Scholar
  4. Park JR, Kim RJ, Lee YK, Kim SR, Roh KJ, Oh SH, et al. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells. J Hepatol 2011; 54: 122-31.10.1016/j.jhep.2010.06.02620952084
    Search in Google Scholar
  5. Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S, et al. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids. Radiol Oncol 2011; 45: 102-15.10.2478/v10019-011-0015-6342373122933943
    Search in Google Scholar
  6. Yang ZF, Ngai P, Ho DW, Yu WC, Ng MN, Lau CK, et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008; 47: 919-28.10.1002/hep.2208218275073
    Search in Google Scholar
  7. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, et al. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 2008; 13: 153-66.10.1016/j.ccr.2008.01.01318242515
    Search in Google Scholar
  8. Tomuleasa C, Soritau O, Rus-Ciuca D, Pop T, Todea D, Mosteanu O, et al. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma. J Gastrointestin Liver Dis 2010; 19: 61-7.
    Search in Google Scholar
  9. Kohga K, Tatsumi T, Takehara T, Tsunematsu H, Shimizu S, Yamamoto M, et al. Expression of CD133 confers malignant potential by regulating metallo-proteinases in human hepatocellular carcinoma. J Hepatol 2010; 52: 872-9.10.1016/j.jhep.2009.12.03020395004
    Search in Google Scholar
  10. Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008; 6: 1146-53.10.1158/1541-7786.MCR-08-003518644979
    Search in Google Scholar
  11. Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Exp Mol Pathol 2011; 90: 66-73.10.1016/j.yexmp.2010.10.00320969862
    Search in Google Scholar
  12. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, Iwama A, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cel1-1ike properties. Hepatology 2006; 44: 240-51.10.1002/hep.2122716799977
    Search in Google Scholar
  13. Cui F, Wang J, Chen D, Chen YJ. CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer. Oncol Rep 2011; 25: 701-8.
    Search in Google Scholar
  14. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-35.10.1016/j.cell.2005.03.03215960971
    Search in Google Scholar
  15. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007; 120: 1444-50.10.1002/ijc.2247617205516
    Search in Google Scholar
  16. Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133+ hepatocel1u1ar carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 2006; 351: 820-4.10.1016/j.bbrc.2006.10.12817097610
    Search in Google Scholar
  17. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132: 2542-56.10.1053/j.gastro.2007.04.02517570225
    Search in Google Scholar
  18. Khan MS, Halagowder D, Devaraj SN. Methylated chrysin induces co-ordinated attenuation of the canonical Wnt and NF-kB signaling pathway and upregulates apoptotic gene expression in the early hepatocarcinogenesis rat model. Chem Bio Interact 2011; 193: 12-21.10.1016/j.cbi.2011.04.00721554863
    Search in Google Scholar
  19. Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006; 94: 776-80.10.1038/sj.bjc.6603023236137716495913
    Search in Google Scholar
  20. Hashimoto T, Kikkawa U, Kamada S. Contribution of caspase(s) to the cell cycle regulation at mitotic phase. PLoS One 2011; 6: e18449.10.1371/journal.pone.0018449306816821479177
    Search in Google Scholar
  21. Depraetere V, Golstein P. Dismantling in cell death: molecular mechanisms and relationship to caspase activation. Scand J Immunol 2005; 47: 523-31.10.1046/j.1365-3083.1998.00363.x9652819
    Search in Google Scholar
  22. Vaishnav M, MacFarlane M, Dickens M. Disassembly of the JIP1/JNK molecular scaffold by caspase-3-mediated cleavage of JIP1 during apoptosis. Exp Cell Res 2011; 317: 1028-39.10.1016/j.yexcr.2011.01.011306333921237154
    Search in Google Scholar
  23. Rudner J, Elsaesser SJ, Jendrossek V, Huber SM. Anti-apoptotic Bcl-2 fails to form efficient complexes with pro-apoptotic Bak to protect from Celecoxibinduced apoptosis. Biochemical Pharmacol 2011; 81: 32-42.10.1016/j.bcp.2010.09.00220836993
    Search in Google Scholar
  24. Kim R, Emi M, Matsuura K, Tanabe K. Therapeutic potential of antisense Bcl-2 as a chemosensitizer for patients with gastric carcinoma. Gan To Kagaku Ryoho. 2005; 32: 1540-5.10.1200/jco.2005.23.16_suppl.4050
    Search in Google Scholar
  25. Barrezueta LF, Oshima CT, Lima FO, De Oliveira Costa H, Gomes TS, Neto RA, et al. The intrinsic apoptotic signaling pathway in gastric adenocarcinomas of Brazilian patients: Immunoexpression of the Bcl-2 family (Bcl-2, Bcl-x, Bak, Bax, Bad) determined by tissue microarray analysis. Mol Med Report 2010; 3: 261-7.10.3892/mmr_000000249
    Search in Google Scholar
  26. Chami M, Prandini A, Campanella M, Pinton P, Szabadkai G, Reed JC, et al. Bcl-2 and bax exert opposing effects on Ca2+ signaling, which do not depend on their putative pore-forming region. J Biol Chem 2004; 279: 54581-9.10.1074/jbc.M40966320015485871
    Search in Google Scholar
  27. Samuel MS, Lopez JI, McGhee EJ, Croft DR, Strachan D, Timpson P, et al. Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth. Cancer Cell 2011; 19: 776-91.10.1016/j.ccr.2011.05.008311554121665151
    Search in Google Scholar
  28. Lee YS, Mollah ML, Sohn KC, Shi G, Kim DH, Kim KH, et al. Ki-Hwan Kim ID3 mediates X-ray-induced apoptosis of keratinocytes through the regulation of β-catenin. J Dermatol Sci 2010; 60: 138-42.10.1016/j.jdermsci.2010.09.00221030215
    Search in Google Scholar
  29. Luo H, Yang Y, Huang F, Li F, Jiang Q, Shi K, et al. Selenite induces apoptosis in colorectal cancer cells via AKT-mediated inhibition of β-catenin survival axis. Cancer Lett 2012; 315: 78-85.10.1016/j.canlet.2011.10.01422074856
    Search in Google Scholar
  30. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005; 65: 6029-33.10.1158/0008-5472.CAN-05-013716024602
    Search in Google Scholar
  31. Bachour T, Bennett K. The role of microRNAs in breast cancer. J Assoc Genet Technol 2011; 37: 21-8.
    Search in Google Scholar
  32. Lin Z, Flemington EK. miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett 2011; 305: 186-99.10.1016/j.canlet.2010.08.018302382320943311
    Search in Google Scholar
  33. Kerr TA, Korenblat KM, Davidson NO. MicroRNAs and liver disease. Transl Res 2011; 157: 241-52.10.1016/j.trsl.2011.01.008306395221420035
    Search in Google Scholar
  34. Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M, et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 2008; 23: 87-94.10.1111/j.1440-1746.2007.05223.x18171346
    Search in Google Scholar
  35. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593-601.10.1038/ncb172218376396
    Search in Google Scholar
  36. Feitelson MA, Lee J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett 2007; 252: 157-70.10.1016/j.canlet.2006.11.01017188425
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10019-012-0025-z | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 233 - 241
Published on: Apr 11, 2012
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
liver cancer stem cells,
miR-548c-5p,
apoptosis,
NF-kB,
β-catenin
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2012 Lin Fang, Hai-Bing Zhang, Hua Li, Yong Fu, Guang-Shun Yang, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 46 (2012): Issue 3 (September 2012)